Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.64 and traded as low as $2.92. Hypera shares last traded at $2.92, with a volume of 2,091 shares trading hands.
Hypera Stock Up -2.5 %
The firm has a market capitalization of $1.85 billion, a P/E ratio of 5.38 and a beta of 1.02. The firm’s 50-day simple moving average is $3.62 and its 200-day simple moving average is $4.64.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Industrial Products Stocks Investing
- 2 Drone Stocks Surging from Increased Media Attention
- Which Wall Street Analysts are the Most Accurate?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
